Stem Cell Stocks 4/3/09: The Week That Was

This was another lackluster week for the stem cell stocks. Most of these stocks were slightly down, while once again, the overall market edged higher. In an incredible sign of market strength, the the Dow closed the week over 8000. The stem cell stocks are still not participating in the rally.

Top Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy International Inc. (SCII.OB) = Up 67% for the week; Last week the company announced its first new product, a cosmetic face cream made with stem cells. The cream is said to rejuvenate the skin and provide excellent health for facial tissues. The market seemed to be impressed.

Worst Stem Cell Stock Performer(s) for Last Week

- Cord Blood America (CBAI.OB) = Down -23% for the week; After a brief rise, the stock appears to be under selling pressure after it was voted to allow management to increase the number authorized common shares.

Stem Cell Stocks Current Price and % Up or Down 3/30/09 - 4/03/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.35; Down -1%
Aastrom Biosciences (ASTM) = Current Price: $0.365; Down -9%
BioTime, Inc. (BTIM) = Current Price: $2.11; Unchanged
Celgene Corp (CELG) = Current Price: $42.15; Down -8%
Cytori Therapeutics (CYTX) = Current Price: $1.81; Up 1%
Geron Corp (GERN) = Current Price: $4.51; Down -8%
ThermoGenesis (KOOL) = Current Price: $0.57; Down -5%
Osiris Therapeutics (OSIR) = Current Price: $13.66; Down -5%
StemCell Inc. (STEM) = Current Price: $1.66; Down -8%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.105; Down -16%
Athersys Inc. (ATHX) = Current Price: $0.80; Down -8%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.085; Down -8%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.55; Down -8%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0066; Down -23%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.512; Down -17%
Neuralstem (CUR) = Current Price: $1.27; Up 20%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.49; Down -2%
LifeStem International (LSTM.OB) = Current Price: $0.01; Up 33%
MultiCell Technologies (MCET.OB) = Current Price: $0.0125; Down -7%
Pluristem Therapeutics (PSTI) = Current Price: $1.24; Down -8%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.125; Up 67%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.005; Down -17%

Possible Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Ending Thoughts:

The stem cell stocks definitely need to get moving in the next couple of weeks to maintain any level of relevancy. With the market bulling its way forward and so many other sectors recovering with such strength, these stocks are in desperate need of a charge.

No comments:

Post a Comment